GHENT UNIVERSITY Karoline FONCK - International Centre for ...

GHENT UNIVERSITY Karoline FONCK - International Centre for ... GHENT UNIVERSITY Karoline FONCK - International Centre for ...

05.04.2013 Views

Our risk score algorithm (C) resulted in a sensitivity of 66% with PPV of 24% among nonpregnant women. The results among pregnant women were less good and comparable with what Mayaud et al. had found in Mwanza. Using this flow chart, the rate of overtreatment in non-pregnant women was 46% while it was 33% in pregnant women. We included several signs in the flow chart. Among pregnant women, however, none of these signs was associated with cervical infection. This is contrary to findings from Thomas et al. who found that among asymptomatic women in Nairobi, cervical friability was associated with cervical infection. An earlier study in Nairobi among pregnant women had identified friability and endocervical mucopus as predictors of cervical infection (Braddick 1990). And in another study in Nairobi, Temmerman et al. reported an association between gonococcal infection post partum and cervical mucopus. We tested algorithm D based on observation of the color of vaginal discharge. This algorithm does not require the use of a speculum. Algorithm E was based on observation of the cervix hence requiring speculum examination that is seldom possible in health centers in Kenya. Both resulted in too low sensitivity to be of value. Algorithm F combined the risk assessment and the inspection of the vaginal discharge. In both groups of women high sensitivity was reached but with low specificity. Several other combinations of risks, symptoms, and signs were tested but all performed worse. While none of the tested algorithms reached acceptable levels of sensitivity and specificity, the algorithm with risk score performed somewhat better than the algorithm actually in use in Kenya and would identify more true cervical infections although at a higher overall cost. Introducing the risk assessment among non-pregnant women could be an option. It is, however, doubtful that the introduction of the risk score into the existing algorithm, which would imply printing of new charts and retraining of health staff, is worthwhile. Among pregnant women this flow chart would fail to identify cervical infections. Treatment of pregnant women with vaginal discharge might be considered for both vaginal and cervical infections on the first visit. Further operational research is needed to assess the rate of follow up and return visits among these women. We can conclude that simple, cheap, and reliable tests for the diagnosis of cervical infection in women are still urgently needed. DIAGNOSIS AND MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS 67

C HAPTER 6 PREVENTION OF SEXUALLY TRANSMITTED 6.1. Syphilis Control During Pregnancy: INFECTIONS INCLUDING HIV Effectiveness and Sustainability of a Decentralized Program. Summary Published in the American Journal of Public Health 2001; 91:705-7 by Fonck K, Claeys P, Bashir F, Bwayo J, Fransen L and Temmerman M. This study sought to assess the performance, effectiveness, and costs of a decentralized antenatal syphilis-screening program in Nairobi, Kenya. Health clinic data, quality control data, and costs were analyzed. The rapid plasma regain (RPR) seroprevalence was 3.4%. In terms of screening, treatment, and partner notification, the program’s performance was adequate. The program’s effectiveness was problematic because of false-negative and falsepositive RPR results. The cost per averted case was calculated to be US$ 95 to US$ 112. The sustainability of this labor-intensive program is threatened by costs and logistic constraints. Alternative strategies, such as the mass epidemiologic treatment of pregnant women in high-prevalence areas, should be considered. Introduction Pregnant women who are seroreactive to syphilis are at an increased risk for spontaneous abortion, stillbirth, prematurity, and perinatal death (Schultz 1990, Watts 1984, Temmerman 1992, Berkowitz 1993, How 1994). In Africa, the reported prevalence of syphilis in pregnancy ranges from 3.6% to 19% (Meda 1997, Grosskurth 1995, Wawer 1998, Mayaud 1997, Wilkinson 1997, Newell 1993, Temmerman 1992). Although syphilis screening in pregnancy is a national health policy in most African countries, few screening programs achieve implementation, mainly owing to financial and logistical constraints. Chapter 6 68

C HAPTER 6<br />

PREVENTION OF SEXUALLY TRANSMITTED<br />

6.1. Syphilis Control During Pregnancy:<br />

INFECTIONS INCLUDING HIV<br />

Effectiveness and Sustainability of a Decentralized Program.<br />

Summary<br />

Published in the American Journal of Public Health 2001;<br />

91:705-7 by Fonck K, Claeys P, Bashir F, Bwayo J, Fransen L<br />

and Temmerman M.<br />

This study sought to assess the per<strong>for</strong>mance, effectiveness, and costs of a decentralized<br />

antenatal syphilis-screening program in Nairobi, Kenya. Health clinic data, quality control<br />

data, and costs were analyzed. The rapid plasma regain (RPR) seroprevalence was 3.4%. In<br />

terms of screening, treatment, and partner notification, the program’s per<strong>for</strong>mance was<br />

adequate. The program’s effectiveness was problematic because of false-negative and falsepositive<br />

RPR results. The cost per averted case was calculated to be US$ 95 to US$ 112.<br />

The sustainability of this labor-intensive program is threatened by costs and logistic<br />

constraints. Alternative strategies, such as the mass epidemiologic treatment of pregnant<br />

women in high-prevalence areas, should be considered.<br />

Introduction<br />

Pregnant women who are seroreactive to syphilis are at an increased risk <strong>for</strong> spontaneous<br />

abortion, stillbirth, prematurity, and perinatal death (Schultz 1990, Watts 1984, Temmerman<br />

1992, Berkowitz 1993, How 1994). In Africa, the reported prevalence of syphilis in pregnancy<br />

ranges from 3.6% to 19% (Meda 1997, Grosskurth 1995, Wawer 1998, Mayaud 1997,<br />

Wilkinson 1997, Newell 1993, Temmerman 1992). Although syphilis screening in pregnancy<br />

is a national health policy in most African countries, few screening programs achieve<br />

implementation, mainly owing to financial and logistical constraints.<br />

Chapter 6 68

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!